Lisa Crossley

Dr. Crossley is an accomplished healthcare technology executive with a proven track record of successfully building and leading global tech companies. She has diverse experience across multiple market segments, including healthcare information technology, therapeutics, medical devices, life science tools and diagnostics. Most recently, Dr. Crossley was CEO of VitalHub Corp., a healthcare IT company that provides clinicians with secure mobile access to comprehensive patient health information. Her prior experience includes leadership positions as CEO of Quantum Dental Technologies and President & CEO of Natrix Separations. Dr. Crossley has raised over $35 Million in venture capital and angel financing, negotiated channel partner agreements with major multinational market leaders and built customer bases in North America, Europe and Asia. She holds a B.Sc. in Anatomy & Cell Biology from McGill University and a B.A.Sc. and Ph.D. in Chemical Engineering from Queen’s University, and is a licensed Professional Engineer in the Province of Ontario. Dr. Crossley currently serves on the Genome Alberta Board of Directors and on the Mitacs Research Council. She has previously acted as a Board Director for the Ontario Bioscience Innovation Organization (OBIO), Viron Therapeutics, Boyd Technologies, and Women in Science and Technology Businesses (WSTB) and has held numerous Advisory Board appointments. She was a member of the Council of Canadian Academies’ Expert Panel commissioned by Industry Canada to conduct a comprehensive assessment of the State of Industrial R&D in Canada.